نتائج البحث - "MB Urowitz"

المؤلفون: Askanase AD; Department of Medicine, Columbia University Irving Medical Center, New York, New York, USA., Furie RA; Division of Rheumatology, Northwell Health, Great Neck, New York, USA., Dall'Era M; Division of Rheumatology, University of California San Francisco School of Medicine, San Francisco, California, USA., Bomback AS; Department of Medicine, Columbia University Irving Medical Center, New York, New York, USA., Schwarting A; Rheumatology Center Rhineland Palatinate, Bad Kreuznach, Germany.; University Medical Centre of the Johannes Gutenberg University Mainz, Mainz, Germany., Zhao MH; Renal Division, Peking University First Hospital, Beijing, China., Bruce IN; Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK., Khamashta M; Medical Affairs, GSK, Dubai, UAE., Rubin B; US Medical Affairs, GSK, Research Triangle Park, North Carolina, USA., Carroll A; US Medical Affairs, GSK, Research Triangle Park, North Carolina, USA., Daniels M; Global Medical Affairs, GSK, Stevenage, UK., Levy RA; Specialty Care, Global Medical Affairs, GlaxoSmithKline, Philadelphia, Pennsylvania, USA roger.x.levy@gsk.com., van Vollenhoven R; Department of Rheumatology, Amsterdam Rheumatology and Immunology Center and Amsterdam University Medical Centers, Amsterdam, The Netherlands., Urowitz MB; Professor Emeritus, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.

المصدر: Lupus science & medicine [Lupus Sci Med] 2024 May 22; Vol. 11 (1). Date of Electronic Publication: 2024 May 22.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: BMJ Country of Publication: England NLM ID: 101633705 Publication Model: Electronic Cited Medium: Print ISSN: 2053-8790 (Print) Linking ISSN: 20538790 NLM ISO Abbreviation: Lupus Sci Med Subsets: MEDLINE

مواضيع طبية MeSH: Lupus Erythematosus, Systemic*/drug therapy , Lupus Erythematosus, Systemic*/complications , Immunosuppressive Agents*/therapeutic use , Immunosuppressive Agents*/adverse effects, Humans ; Disease Progression ; Severity of Illness Index

Find this article in full text from ProQuest

Full Text Finder

9

دورية أكاديمية

Remission and low disease activity are associated with lower healthcare costs: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort.

المؤلفون: Barber MRW; Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada., Ugarte-Gil MF; Grupo Peruano de Estudio de Enfermedades Autoinmunes Sistémicas, Universidad Cientifica del Sur, Lima, Peru.; Rheumatology, Hospital Nacional Guillermo Almenara Irigoyen, EsSalud, Lima, Peru., Hanly JG; Division of Rheumatology, Department of Medicine and Department of Pathology, Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia, Canada.; Dalhousie University, Halifax, Nova Scotia, Canada., Urowitz MB; Lupus Program, Centre for Prognosis Studies in the Rheumatic Diseases, University of Toronto, Toronto Western Hospital, Toronto, Ontario, Canada.; Krembil Research Institute, Toronto, Ontario, Canada., St-Pierre Y; Research Institute of the McGill University Health Center, Montreal, Quebec, Canada., Gordon C; Rheumatology Research Group, Birmingham University Medical School, Birmingham, UK., Bae SC; Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Korea (the Republic of).; Hanyang Institute of Bioscience and Biotechnology, Seoul, Korea (the Republic of)., Romero-Diaz J; Immunology and Rheumatology, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Tlalpan, Mexico., Sanchez-Guerrero J; University Health Network, Toronto, Ontario, Canada.; Mount Sinai Hospital, Toronto, Ontario, Canada., Bernatsky S; Research Institute of the McGill University Health Center, Montreal, Quebec, Canada., Wallace DJ; Division of Rheumatology, Cedars-Sinai Medical Center, Los Angeles, California, USA., Isenberg DA; Centre for Rheumatology, Department of Medicine, University College London, London, UK., Rahman A; Centre for Rheumatology, Department of Medicine, University College London, London, UK., Merrill JT; Department of Clinical Pharmacology, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA., Fortin PR; Centre ARThrite, CHU de Québec, Université Laval, Quebec City, Quebec, Canada., Gladman DD; Krembil Research Institute, Toronto, Ontario, Canada.; Lupus Program, Centre for Prognosis in The Rheumatic Diseases, University of Toronto, Toronto, Ontario, Canada., Bruce IN; Centre for Musculoskeletal Research, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.; The Kellgren Centre for Rheumatology, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK., Petri M; Division of Rheumatology, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA., Ginzler EM; Department of Medicine, SUNY Downstate Medical Center, Brooklyn, New York, USA., Dooley MA; Thurston Arthritis Research Centre, University of North Carolina, Chapel Hill, North Carolina, USA., Ramsey-Goldman R; Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA., Manzi S; Lupus Center of Excellence, Allegheny Health Network, Pittsburgh, Pennsylvania, USA., Jönsen A; Lund University, Clinical Sciences, Lund, Sweden., van Vollenhoven RF; Rheumatology and Immunology Center, University of Amsterdam, Amsterdam, The Netherlands., Aranow C; The Feinstein Institute for Medical Research, Manhasset, New York, USA., Mackay M; Feinstein Institute for Medical Research, Manhasset, New York, USA., Ruiz-Irastorza G; Biobizkaia Health Research Institute, Hospital Universitario Cruces, Barakaldo, Spain., Lim SS; School of Medicine, Emory University, Atlanta, Georgia, USA., Inanc M; Division of Rheumatology, Department of Internal Medicine, Istanbul University, Istanbul Medical Faculty, Capa, Istanbul, Turkey., Kalunian KC; University of California School of Medicine, La Jolla, California, USA., Jacobsen S; Copenhagen Lupus and Vasculitis Clinic, Center for Rheumatology and Spine Diseases, Rigshospitalet, Copenhagen, Denmark., Peschken CA; University of Manitoba, Winnipeg, Manitoba, Canada., Kamen DL; Medical University of South Carolina, Charleston, South Carolina, USA., Askanase A; Division of Rheumatology, Columbia University Lupus Center, Columbia University College of Physicians & Surgeons, New York, New York, USA., Pons-Estel BA; Grupo Oroño, Centro Regional de Enfermedades Autonmunes y Reumáticas, Rosario, Argentina., Cardwell FS; Geography & Environmental Management, University of Waterloo, Waterloo, Ontario, Canada., Alarcón GS; Department of Medicine, Division of Clinical Immunology and Rheumatology, School of Medicine, The University of Alabama, Birmingham, Alabama, USA., Clarke AE; Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada aeclarke@ucalgary.ca.

المصدر: Annals of the rheumatic diseases [Ann Rheum Dis] 2024 May 16. Date of Electronic Publication: 2024 May 16.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BMJ Country of Publication: England NLM ID: 0372355 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-2060 (Electronic) Linking ISSN: 00034967 NLM ISO Abbreviation: Ann Rheum Dis Subsets: MEDLINE

Full Text Finder

10

دورية أكاديمية

Anti-KIF20B autoantibodies are associated with cranial neuropathy in systemic lupus erythematosus.

المؤلفون: Krustev E; Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada., Hanly JG; Division of Rheumatology, Department of Medicine and Department of Pathology, Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, Nova Scotia, Canada., Chin R; Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada., Buhler KA; Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada., Urowitz MB; Lupus Program, Centre for Prognosis Studies in The Rheumatic Disease and Krembil Research Institute, Toronto Western Hospital and University of Toronto, Toronto, Ontario, Canada., Gordon C; Rheumatology Research Group, Institute of Inflammation and Ageing, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK., Bae SC; Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Hanyang University Institute for Rheumatology and Hanyang Institute of Bioscience and Biotechnology, Seoul, Republic of Korea., Romero-Diaz J; Immunology and Rheumatology, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Ciudad de Mexico, Mexico., Sánchez-Guerrero J; Mount Sinai Hospital and University Health Network, Toronto, Ontario, Canada., Bernatsky S; Divisions of Rheumatology and Clinical Epidemiology, McGill University Health Centre, Montreal, Quebec, Canada., Wallace DJ; Rheumatology, Cedars-Sinai Medical Center, Los Angeles, California, USA.; David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA., Isenberg D; Centre for Rheumatology, Department of Medicine, University College London, London, UK., Rahman A; Centre for Rheumatology, Department of Medicine, University College London, London, UK., Merrill JT; Department of Clinical Pharmacology, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA., Fortin PR; Division of Rheumatology, CHU de Québec, Universite Laval, Quebec City, Quebec, Canada., Gladman DD; Lupus Program, Centre for Prognosis Studies in The Rheumatic Disease and Krembil Research Institute, Toronto Western Hospital and University of Toronto, Toronto, Ontario, Canada., Bruce IN; Centre for Musculoskeletal Research, Faculty of Biology, Medicine and Health, The University of Manchester and The Kellgren Centre for Rheumatology, Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK., Petri MA; Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Ginzler EM; Medicine, SUNY Downstate Medical Center, New York City, New York, USA., Dooley MA; Thurston Arthritis Research Center, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Ramsey-Goldman R; Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA., Manzi S; Allegheny Health Network, Pittsburgh, Pennsylvania, USA., Jönsen A; Department of Rheumatology, Lund University Department of Clinical Sciences Lund, Lund, Sweden., Alarcón GS; Department of Medicine, The University of Alabama at Birmingham Heersink School of Medicine, Birmingham, Alabama, USA., van Vollenhoven RF; Department of Rheumatology and Clinical Immunology, University of Amsterdam, Amsterdam, Noord-Holland, The Netherlands., Aranow C; Center for Autoimmune and Musculoskeletal Disease, Northwell Health Feinstein Institutes for Medical Research, Manhasset, New York, USA., Mackay M; Center for Autoimmune and Musculoskeletal Disease, Northwell Health Feinstein Institutes for Medical Research, Manhasset, New York, USA., Ruiz-Irastorza G; Autoimmune Diseases Research Unit, Department of Internal Medicine, BioCruces Health Research Institute, Hospital Universitario Cruces, University of the Basque Country, Barakaldo, Spain., Lim S; Division of Rheumatology, Emory University School of Medicine, Atlanta, Georgia, USA., Inanc M; Division of Rheumatology, Department of Internal Medicine, Istanbul Medical Faculty, Istanbul University, Fatih, Turkey., Kalunian KC; University of California San Diego School of Medicine, La Jolla, California, USA., Jacobsen S; Department of Rheumatology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Peschken CA; University of Manitoba, Winnipeg, Manitoba, Canada., Kamen DL; Medical University of South Carolina, Charleston, South Carolina, USA., Askenase A; Columbia University Medical Center, New York City, New York, USA., Buyon J; Rheumatology, NYU Langone Health, New York City, New York, USA., Fritzler MJ; Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada., Clarke AE; Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada., Choi MY; Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada may.choi@ucalgary.ca.; McCaig Institute for Bone and Joint Health, Calgary, Alberta, Canada.

المصدر: Lupus science & medicine [Lupus Sci Med] 2024 Apr 09; Vol. 11 (1). Date of Electronic Publication: 2024 Apr 09.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BMJ Country of Publication: England NLM ID: 101633705 Publication Model: Electronic Cited Medium: Print ISSN: 2053-8790 (Print) Linking ISSN: 20538790 NLM ISO Abbreviation: Lupus Sci Med Subsets: MEDLINE

مواضيع طبية MeSH: Autoantibodies* , Kinesins* , Lupus Erythematosus, Systemic*/complications , Lupus Erythematosus, Systemic*/diagnosis, Female ; Humans ; Male ; Biomarkers

Find this article in full text from ProQuest

Full Text Finder

تنقيح النتائج